Greenlight Biosciences Holdings Pbc (GRNA) Gross Profit Margin starting from the first quarter 2023 to first quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Greenlight Biosciences Holdings Pbc  (NASDAQ: GRNA)


Greenlight Biosciences Holdings Pbc's Gross Profit Margin by quarter

Trends, Rankings, Statistics



GRNA Gross Profit Margin (Mar 31 2023)
Q1
(Dec 31 2022)
Q4
(Sep 30 2022)
Q3
(Jun 30 2022)
Q2
(Mar 31 2022)
Q1
Y / Y Revenue Change 1386.38 %
Seq. Revenue Change 26.36 %
Revenue In Millions $3.82
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 824
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting First Quarter 2023 Gross Profit Margin



Observing first quarter 2023 results within Biotechnology & Pharmaceuticals industry 59 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
GRNA's Gross Profit Margin first quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 60
Healthcare Sector # 242
Overall # 824

Gross Profit Margin Statistics
High Average Low
100 % 100 % 100 %
(Mar 31 2023)  




Other Gross Profit Margin Profitability Ratios
GRNA's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
GRNA's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for GRNA's Competitors
Gross Profit Margin Profit Margin for Greenlight Biosciences Holdings Pbc's Suppliers
Gross Profit Margin Profit Margin for GRNA's Customers

You may also want to know
GRNA's Annual Growth Rates GRNA's Profitability Ratios GRNA's Asset Turnover Ratio GRNA's Dividend Growth
GRNA's Roe GRNA's Valuation Ratios GRNA's Financial Strength Ratios GRNA's Gross Profit Growth
GRNA's Roa GRNA's Inventory Turnover Ratio GRNA's Growth Rates GRNA's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2023, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginMar 31 2023 MRQ Gross ProfitMar 31 2023 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.